Literature DB >> 17883887

Methods for removing bacterial biofilms: in vitro study using clinical chronic rhinosinusitis specimens.

Martin Desrosiers1, Matthew Myntti, Garth James.   

Abstract

BACKGROUND: Bacterial biofilms may be involved in refractory chronic rhinosinusitis (CRS). In vitro, we studied methods for removing biofilms formed by Staphylococcus aureus and Pseudomonas aeruginosa.
METHODS: Bacterial isolates were obtained from patients with refractory CRS and were plated and treated with either static administration of citric acid/zwitterionic surfactant (CAZS), saline delivered with hydrodynamic force, or CAZS delivered hydrodynamically. Results were assessed by counting colony-forming units (CFUs) and by confocal scanning laser microscopy (CSLM).
RESULTS: All treatments produced significant reductions in CFU counts (p >or= 0.002). Hydrodynamic CAZS provided the greatest reduction, decreasing CFU counts from control values by 3.9 +/- 0.3 logs and 5.2 +/- 0.5 logs for S. aureus and P. aeruginosa, respectively (99.9% reduction; p = 0.001). CSLM showed decreases in biofilm coverage.
CONCLUSION: Hydrodynamic delivery of a soap-like surfactant and a calcium-ion sequestering agent may disrupt biofilms associated with CRS. Our results may be relevant to a new approach to refractory CRS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17883887     DOI: 10.2500/ajr.2007.21.3069

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  13 in total

1.  The impact of intraoperative saline irrigations on bacterial load within the maxillary sinus.

Authors:  Kristin A Seiberling; Richard K McHugh; Wilson Aruni; Christopher A Church
Journal:  Int Forum Allergy Rhinol       Date:  2011-06-14       Impact factor: 3.858

2.  Using surface plasmon resonance imaging to study bacterial biofilms.

Authors:  Pegah N Abadian; Nil Tandogan; John J Jamieson; Edgar D Goluch
Journal:  Biomicrofluidics       Date:  2014-03-05       Impact factor: 2.800

3.  Development and application of a polymicrobial, in vitro, wound biofilm model.

Authors:  J Woods; L Boegli; K R Kirker; A M Agostinho; A M Durch; E Delancey Pulcini; P S Stewart; G A James
Journal:  J Appl Microbiol       Date:  2012-03-13       Impact factor: 3.772

4.  Topical Drug Delivery for Chronic Rhinosinusitis.

Authors:  Jonathan Liang; Andrew P Lane
Journal:  Curr Otorhinolaryngol Rep       Date:  2012-12-27

Review 5.  Surfactants in the management of rhinopathologies.

Authors:  Philip L Rosen; James N Palmer; Bert W O'Malley; Noam A Cohen
Journal:  Am J Rhinol Allergy       Date:  2013 May-Jun       Impact factor: 2.467

6.  Biofilms in pediatric respiratory and related infections.

Authors:  Yi-Chun Carol Liu; J Christopher Post
Journal:  Curr Allergy Asthma Rep       Date:  2009-11       Impact factor: 4.806

Review 7.  The role of bacterial biofilms and the pathophysiology of chronic rhinosinusitis.

Authors:  Shaun J Kilty; Martin Y Desrosiers
Journal:  Curr Allergy Asthma Rep       Date:  2008-05       Impact factor: 4.919

8.  Efficacy of citric acid denture cleanser on the Candida albicans biofilm formed on poly(methyl methacrylate): effects on residual biofilm and recolonization process.

Authors:  Fernanda Faot; Yuri Wanderley Cavalcanti; Martinna de Mendonça e Bertolini; Luciana de Rezende Pinto; Wander José da Silva; Altair Antoninha Del Bel Cury
Journal:  BMC Oral Health       Date:  2014-06-23       Impact factor: 2.757

9.  Evaluation of a 2-aminoimidazole variant as adjuvant treatment for dermal bacterial infections.

Authors:  G Logan Draughn; C Leigh Allen; Patricia A Routh; Maria R Stone; Kelly R Kirker; Laura Boegli; Ryan M Schuchman; Keith E Linder; Ronald E Baynes; Garth James; Christian Melander; Angela Pollard; John Cavanagh
Journal:  Drug Des Devel Ther       Date:  2017-01-16       Impact factor: 4.162

10.  Innate immunity and chronic rhinosinusitis: What we have learned from animal models.

Authors:  Nyall R London; Andrew P Lane
Journal:  Laryngoscope Investig Otolaryngol       Date:  2016-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.